Docgo INC

DocGo Inc. has received an additional 180-day extension until January 25, 2027, to regain compliance with Nasdaq's minimum bid price requirement, with options including a reverse stock split.

DocGo Inc. has extended its existing share repurchase program through December 31, 2026, maintaining the authorized repurchase amount of $26 million.

DocGo Inc. held its 2026 Annual Meeting of Stockholders, where shareholders approved a reverse stock split and ratified the appointment of its independent auditor.

DocGo Inc. announces changes to its Board of Directors, including the departure of Stephen K. Klasko, MD, and the appointment of Michael Burdiek as Independent Chair.

DocGo Inc. announced significant losses for 2025 due to migrant program wind-down, but raised its 2026 revenue and adjusted EBITDA guidance while initiating a strategic alternatives review.

DocGo Inc. received a notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement, initiating a 180-day compliance period.

DocGo Inc. reported a net loss of $16.7 million for the first quarter of 2026, with revenues decreasing 21.4% year-over-year, primarily due to the wind-down of migrant-related services.

DocGo Inc. reported a significant net loss and revenue decline in Q3 2025, primarily due to the wind-down of large migrant-related services, despite growth in its Transportation Services segment.

DocGo Inc. reported a significant net loss and over 50% revenue decline in Q2 2025, primarily driven by the wind-down of large migrant-related services, despite growth in its transportation segment.

DocGo Inc.'s Q1 2025 revenue decreased by 50% year-over-year due to the wind-down of migrant-related services, resulting in a net loss of $11.1 million.

DocGo Inc. experienced a revenue decrease in Q3 2024 due to the wind-down of migrant-related services, while its Transportation Services segment saw growth.

DocGo Inc. announced a profitable second quarter with a significant revenue increase of 31.4% year-over-year, driven by growth in both Mobile Health and Transportation Services.

DocGo Inc.'s 2024 10-K filing reveals a year of strategic adjustments, including a net income of $13.4 million amidst declining migrant-related service revenues and growth in transportation services.

DocGo Inc.'s 10-K filing details the company's capital structure, including common and preferred stock authorizations, and outlines key corporate governance provisions.

DocGo Inc. CEO Lee Bienstock reported a transaction involving the withholding of restricted stock units to cover tax liabilities, alongside details of his beneficial ownership of common stock and unvested RSUs.

DocGo Inc.'s CEO, Lee Bienstock, reported a transaction involving the withholding of 18,811 restricted stock units to cover tax liabilities.

DocGo CEO Lee Bienstock reported the acquisition of over 1.1 million restricted stock units and the disposition of 214,131 units for tax purposes.

DocGo Inc.'s CFO and Treasurer, Norman Rosenberg, reported the acquisition of 429,405 restricted stock units and the disposition of 65,774 shares for tax obligations.

DocGo's Chief Compliance Officer, Stephen Sugrue, reported the acquisition of 321,055 restricted stock units and the disposition of 35,968 units for tax obligations.

DocGo's General Counsel and Secretary, Ely D. Tendler, received a grant of 100,000 restricted stock units and sold 16,850 shares to cover tax obligations.

DocGo Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for June 16, 2026, which will include proposals for a reverse stock split and amendments to its charter.

DocGo Inc. announces its 2025 Annual Meeting of Stockholders to be held on June 17, 2025, outlining key proposals for shareholder voting.

DocGo Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 17, 2025, to vote on director elections, executive compensation, and amendments to the company's charter.

DocGo Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on June 18, 2024, providing details on how stockholders can access proxy materials and vote.

DocGo Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 18, 2024, to vote on director elections, executive compensation, auditor ratification, and other matters.

Stanley Vashovsky, former CEO and Chair of DocGo Inc., has reduced his beneficial ownership in the company to 0.2%, falling below the 5% reporting threshold.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in DocGo Inc. following an internal realignment.

The Vanguard Group has filed a Schedule 13G, revealing a passive beneficial ownership of 5.36% in DocGo Inc.'s common stock as of March 31, 2025.

Deerfield Mgmt, L.P., Deerfield Management Company, L.P., Deerfield Partners, L.P., and James E. Flynn have collectively reduced their beneficial ownership in DocGo Inc. to 4.95% of outstanding common stock, down from 7.05% as of December 31, 2024.